Panacea Biotec Ltd (PANACEABIO) — Announcement | 29 September 2026
Panacea Biotec disclosed two Income Tax demand orders dated September 28, 2026, imposing a combined penalty of ₹4.32 Crore for alleged income misreporting in assessment years 2022-23 and 2023-24, though the company contests the demand and expects no material impact on operations.
About Panacea Biotec Ltd (PANACEABIO)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when PANACEABIO files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track PANACEABIO — Free💡 Ask AI about this filing
📊 More PANACEABIO filings
- Announcement — 26 September 2026Panacea Biotec announced that its trading window will close on October 1, 2026, for all designated p...
- Announcement — 26 September 2026Panacea Biotec disclosed receipt of four income tax demand orders from Delhi's Assistant Commissione...
- share transfer — 15 September 2026Panacea Biotec sent reminder letters to physical shareholders on September 15, 2026, requesting PAN ...
- 🔴 Annual Report — 7 September 2026Panacea Biotec announced that shareholders without registered email addresses will receive a web lin...
- Announcement — 7 September 2026Panacea Biotec disclosed that 6,11,08,526 shares were dematerialized in August 2026 across NSDL and ...
🔥 Also filed on 29 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when PANACEABIO files new disclosures
Track PANACEABIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track PANACEABIO — FreeFree account · 2 AI queries/day